Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Finding drugs that treat the COVID-19 coronavirus may be just as important as developing a vaccine. But it’s much harder to create effective antivirals than antibiotics.
Nevan Krogan, University of California, San Francisco
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven’t been tried before.
The SARS-CoV-2 virus that causes COVID-19 is constantly mutating. What do these mutations reveal about this virus’s evolution? And will this knowledge help us to develop a long-lasting vaccine?
It seems as though every other day we’re told a cure has been found for coronavirus. This is not strictly true – but there are some therapeutic options showing promise.
Under pressure to develop a coronavirus vaccine, researchers have turned to protein synthesis, genetics and hybrid viruses. It is likely a mix of these approaches will be used to fight the coronavirus.
A molecular biologist explains who should get tested, how the tests work and what the US government is doing to make tests available during a rapidly changing crisis.
A new technology has enabled neuroscientists to examine the chemistry of individual brain cells. The finding reveal how genes are regulated differently in brain cells of people with autism compared to neurotypical people.
How do brains convert experiences into memories? New research explores the chain of events by focusing on what genes shift into gear when neurons are firing.
One big challenge for gene therapies is delivering DNA or RNA safely to cells inside patients’ bodies. New nanoparticles could be an improvement over the current standard – repurposed viruses.
Epigenetics is consistent with the theory of evolution – in fact, Darwin predicted that tiny parcels might somehow provide a flow of information from experience to inheritance.